GeneChem is a manager of focused biotechnology venture capital funds. We have over $350M in assets distributed over four funds: GeneChem Technologies, GeneChem Therapeutics, Agechem and AmorChem. Since 1997, GeneChem has been active in investing in companies involved in drug discovery and development. Together, we have invested in over 60 companies located in the US, Canada and Europe. Today, GeneChem has established itself as a leader in the management of focused biotech funds.
| Website | http://www.genechem.com |
| Revenue | $5 million |
| Employees | View employees |
| Founded | 1997 |
| Address | 1 Westmount Sq Ste 800, Montreal, Quebec H3Z 2P9, CA |
| Phone | +1 514-849-7696 |
| Fax | (514) 849-5191 |
| Industry | Finance General, Genetics, Finance, Biotechnology, Health Care |
| Competitors | Roche, Thermo Fisher Scientific, Abbott, Agilent Technologies, Illumina, Exact Sciences, Bio-Rad Laboratories, Myriad Genetics, Zymeworks Inc., Zymergen, Inc. +44 more (view full list) |
| SIC | SIC Code 672 Companies, SIC Code 67 Companies |
| NAICS | NAICS Code 5259 Companies, NAICS Code 52 Companies, NAICS Code 52591 Companies, NAICS Code 525 Companies |
Looking for a particular GeneChem Technologies Venture Fund L.P employee's phone or email?
GeneChem Technologies Venture Fund L.P Questions
The GeneChem Technologies Venture Fund L.P annual revenue was $5 million in 2026.
GeneChem Technologies Venture Fund L.P is based in Montreal, Quebec.
The NAICS codes for GeneChem Technologies Venture Fund L.P are [5259, 52, 52591, 525].
The SIC codes for GeneChem Technologies Venture Fund L.P are [672, 67].
